Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region.
Autore F, Innocenti I, Corrente F, Del Principe MI, Rosati S, Falcucci P, Fresa A, Conte E, Limongiello MA, Renzi D, De Padua L, Andriani A, Pisani F, Cimino G, Tafuri A, Montanaro M, Mauro FR, Del Poeta G, Laurenti L. Autore F, et al. Among authors: innocenti i. Front Oncol. 2020 Jun 10;10:848. doi: 10.3389/fonc.2020.00848. eCollection 2020. Front Oncol. 2020. PMID: 32587827 Free PMC article.
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.
Laurenti L, Tarnani M, De Padua L, Efremov DG, Zini G, Garzia M, Piccirillo N, Chiusolo P, Sorà F, Innocenti I, Sica S, Leone G. Laurenti L, et al. Among authors: innocenti i. Ann Hematol. 2008 Nov;87(11):891-8. doi: 10.1007/s00277-008-0527-3. Epub 2008 Jun 28. Ann Hematol. 2008. PMID: 18587576 Clinical Trial.
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
Laurenti L, Tarnani M, Innocenti I, Savino G, Battendieri R, Larocca LM, Chiusolo P, Sorà F, Sica S, Efremov D, Leone G. Laurenti L, et al. Among authors: innocenti i. J Clin Oncol. 2008 Nov 10;26(32):5299-301. doi: 10.1200/JCO.2008.18.6270. Epub 2008 Oct 14. J Clin Oncol. 2008. PMID: 18854557 No abstract available.
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
Laurenti L, De Padua L, Tarnani M, Piccirillo N, Falcucci P, D'Arena G, Innocenti I, Marietti S, Efremov DG, Chiusolo P, Zini G, Sora' F, Sica S, Leone G. Laurenti L, et al. Among authors: innocenti i. Ann Hematol. 2011 Jan;90(1):59-65. doi: 10.1007/s00277-010-1025-y. Epub 2010 Jul 13. Ann Hematol. 2011. PMID: 20625902
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia.
D'Arena G, D'Auria F, Simeon V, Laurenti L, Deaglio S, Mansueto G, Del Principe MI, Statuto T, Pietrantuono G, Guariglia R, Innocenti I, Martorelli MC, Villani O, De Feo V, Del Poeta G, Musto P. D'Arena G, et al. Among authors: innocenti i. Am J Hematol. 2012 Jun;87(6):628-31. doi: 10.1002/ajh.23170. Epub 2012 Mar 28. Am J Hematol. 2012. PMID: 22460620 Free article.
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience.
Laurenti L, Vannata B, Innocenti I, Autore F, Santini F, Piccirillo N, Za T, Bellesi S, Marietti S, Sica S, Efremov DG, Leone G. Laurenti L, et al. Among authors: innocenti i. Mediterr J Hematol Infect Dis. 2013 May 2;5(1):e2013031. doi: 10.4084/MJHID.2013.031. Print 2013. Mediterr J Hematol Infect Dis. 2013. PMID: 23667729 Free PMC article.
120 results